These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2276986)

  • 1. A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains.
    Howell SA; Mallet AI; Noble WC
    J Appl Bacteriol; 1990 Nov; 69(5):692-6. PubMed ID: 2276986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
    Hitchcock CA; Russell NJ; Barrett-Bee KJ
    Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.
    Marichal P; Gorrens J; Laurijssens L; Vermuyten K; Van Hove C; Le Jeune L; Verhasselt P; Sanglard D; Borgers M; Ramaekers FC; Odds F; Vanden Bossche H
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2663-70. PubMed ID: 10543744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction fragment length polymorphism analysis of azole-resistant and azole-susceptible Candida albicans strains.
    Pearce MA; Howell SA
    J Clin Microbiol; 1991 Jul; 29(7):1364-7. PubMed ID: 1679438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans.
    Hitchcock CA; Barrett-Bee KJ; Russell NJ
    J Med Vet Mycol; 1987 Feb; 25(1):29-37. PubMed ID: 3553525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans.
    Hitchcock CA; Barrett-Bee KJ; Russell NJ
    J Gen Microbiol; 1986 Sep; 132(9):2421-31. PubMed ID: 3540203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains.
    Löffler J; Einsele H; Hebart H; Schumacher U; Hrastnik C; Daum G
    FEMS Microbiol Lett; 2000 Apr; 185(1):59-63. PubMed ID: 10731607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.
    Hitchcock CA; Barrett-Bee KJ; Russell NJ
    J Med Vet Mycol; 1987 Oct; 25(5):329-33. PubMed ID: 3323450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the sterol composition of membranes and morphology in Candida albicans.
    Cannon RD; Kerridge D
    J Med Vet Mycol; 1988 Feb; 26(1):57-65. PubMed ID: 3288743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced production of farnesol by Candida albicans treated with four azoles.
    Hornby JM; Nickerson KW
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2305-7. PubMed ID: 15155241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals.
    Watson PF; Rose ME; Ellis SW; England H; Kelly SL
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1170-5. PubMed ID: 2556119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.
    Gallagher PJ; Bennett DE; Henman MC; Russell RJ; Flint SR; Shanley DB; Coleman DC
    J Gen Microbiol; 1992 Sep; 138(9):1901-11. PubMed ID: 1402791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility and sterol biosynthesis of Candida albicans strains after long-term treatment with azoles in HIV-infected patients.
    Hundt W; Hofmann H
    Infection; 1994; 22(2):124-31. PubMed ID: 8070926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two natural molecules preferentially inhibit azole-resistant Candida albicans with MDR1 hyperactivation.
    Shi HZ; Chang WQ; Zhang M; Lou HX
    Chin J Nat Med; 2019 Mar; 17(3):209-217. PubMed ID: 30910057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
    Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis.
    Heimark L; Shipkova P; Greene J; Munayyer H; Yarosh-Tomaine T; DiDomenico B; Hare R; Pramanik BN
    J Mass Spectrom; 2002 Mar; 37(3):265-9. PubMed ID: 11921367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole sensitivity in Candida albicans.
    Armelles M
    FEMS Microbiol Lett; 1989 Jul; 51(1):153-7. PubMed ID: 2673916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.